Assessing Force-velocity Profile: an Innovative Approach to Optimize Cardiac Rehabilitation in Coronary Patients
NCT ID: NCT04102410
Last Updated: 2022-06-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2019-09-30
2022-04-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The research laboratory "Autonomous Nervous System - Epidemiology, Physiology, Engineering, Health" (SPA-EPIS) has an international expertise in training optimization in top-athletes. He have shown the importance of the relationship between the power-force-velocity profile and athletes performances.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Customization of Cardiac Readaptation Based on Force-velocity Profile and Heart Rate Variability
NCT06107452
Implementation of New Exercise Protocols in Cardiac Rehabilitation.
NCT07161219
Using Cardiopulmonary Exercise Test as an Incentive to Outpatient Cardiac Rehabilitation for Acute Coronary Syndrome Survivors.
NCT05401240
Validation of an Algorithm to Predict the Ventilatory Threshold
NCT04929431
Impact of Additional Resistance Training During Rehabilitation Therapy in Patients With Heart Failure
NCT04688827
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The hypothesis that force-velocity profile could be used in cardiac rehabilitation in coronary patients to induce a force-velocity balance adapted through personalized sessions and regular medical follow-up.
This prospective, controlled, randomized and open label study will attempt to evaluate further the relevance of force or velocity training based on the initial force-velocity profile of coronary patients included in the cardiac rehabilitation program in the University Hospital of Saint-Etienne.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group
Patient with acute coronary syndrome will be included. They will have sprints, vertical jumps, questionary Short Form-12 (SF-12), activity actigraph and program composed of two 2 training strategies.
Sprints
Two sprints of 8 seconds on a cycle ergometer will be performed for determine Force/Velocity Profile (FVP).
Realized at inclusion and 2 months after.
Vertical jumps
Two vertical jumps will be performed. Height of theses vertical jumps will be measured by application "My jump 2" to determine muscle power.
Realized at inclusion and 2 months after.
Questionary Short Form-12 (SF-12)
Questionary Short Form-12 (SF-12) will be performed to evaluate quality of life. It is composed of 12 questions.
Realized at inclusion and 2 months after.
activity actigraph
Activity actigraph will be wearing by patient during 7 consecutive days. It measures the level of physical activity and the sedentary lifestyle of patients.
Realized at inclusion and 2 months after.
Program composed of two 2 training strategies
Program composed of two 2 training strategies according to the initial Force/Velocity Profile (FVP) will be realized at the inclusion.
There are :
* Strategy "experimental-speed": speed training strategy for subjects with a force-speed profile (PFV) in favour of force
* Strategy "experimental-force": force training strategy for subjects with a force-speed profile (PFV) in favour of speed.
Control group
Patient with acute coronary syndrome will be included. They will have sprints, vertical jumps, questionary Short Form-12 (SF-12), activity actigraph and program of usual practice.
Sprints
Two sprints of 8 seconds on a cycle ergometer will be performed for determine Force/Velocity Profile (FVP).
Realized at inclusion and 2 months after.
Vertical jumps
Two vertical jumps will be performed. Height of theses vertical jumps will be measured by application "My jump 2" to determine muscle power.
Realized at inclusion and 2 months after.
Questionary Short Form-12 (SF-12)
Questionary Short Form-12 (SF-12) will be performed to evaluate quality of life. It is composed of 12 questions.
Realized at inclusion and 2 months after.
activity actigraph
Activity actigraph will be wearing by patient during 7 consecutive days. It measures the level of physical activity and the sedentary lifestyle of patients.
Realized at inclusion and 2 months after.
Program of usual practice
Program composed of training in force and speed independently of the initial Force/Velocity Profile (FVP).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sprints
Two sprints of 8 seconds on a cycle ergometer will be performed for determine Force/Velocity Profile (FVP).
Realized at inclusion and 2 months after.
Vertical jumps
Two vertical jumps will be performed. Height of theses vertical jumps will be measured by application "My jump 2" to determine muscle power.
Realized at inclusion and 2 months after.
Questionary Short Form-12 (SF-12)
Questionary Short Form-12 (SF-12) will be performed to evaluate quality of life. It is composed of 12 questions.
Realized at inclusion and 2 months after.
activity actigraph
Activity actigraph will be wearing by patient during 7 consecutive days. It measures the level of physical activity and the sedentary lifestyle of patients.
Realized at inclusion and 2 months after.
Program composed of two 2 training strategies
Program composed of two 2 training strategies according to the initial Force/Velocity Profile (FVP) will be realized at the inclusion.
There are :
* Strategy "experimental-speed": speed training strategy for subjects with a force-speed profile (PFV) in favour of force
* Strategy "experimental-force": force training strategy for subjects with a force-speed profile (PFV) in favour of speed.
Program of usual practice
Program composed of training in force and speed independently of the initial Force/Velocity Profile (FVP).
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Medical revascularization (angioplasty ± stenting) or surgical (coronary artery bypass)
* During initial effort test: Maximum aerobic power≥ 60 watts for women and ≥ 80 watts for men
* Patient affiliated or beneficiary to social security
* Signed informed consent
Exclusion Criteria
* Inability to submit to medical monitoring of the program
* Patient deprived of liberty or patient under guardianship
* Pregnant woman
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jean Monnet University
OTHER
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David HUPIN, MD
Role: PRINCIPAL_INVESTIGATOR
CHU SAINT-ETIENNE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chu Saint-Etienne
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A01613-52
Identifier Type: OTHER
Identifier Source: secondary_id
1708238
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.